Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Histiocytoma, Malignant Fibrous × Specimen Handling × Clear all

Sponsor

Conditions

Neoplasm Metastasis 7 Multiple Myeloma 7 Lung Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Neuroblastoma 5 Melanoma 5 Fallopian Tube Neoplasms 5 Burkitt Lymphoma 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Wilms Tumor 3 Triple Negative Breast Neoplasms 3 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Malignant Solid Neoplasm 3 Leukemia, Biphenotypic, Acute 3 Histiocytosis, Langerhans-Cell 3 Hepatoblastoma 3 Hematologic Neoplasms 3 Glioma 3 Ependymoma 3 Central Nervous System Neoplasms 3 Small Cell Lung Carcinoma 2

Interventions

Doxorubicin 5 pazopanib 3 Ifosfamide 3 pembrolizumab 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 tremelimumab 1 temsirolimus 1 sintilimab 1 saracatinib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Sorafenib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Nivolumab 1 Neoadjuvant Therapy 1 Methotrexate 1 MLN 8237 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡